A Prospective, Double Blind, Randomized, Placebo Controlled Interventional Study, to evaluate Safety and Efficacy of Centella Asiatica Extract tablets in Improving MPOD Levels in Elderly Volunteers.

GENENCELL CO LTD0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•a.Volunteers of either sex, between 45 to 65 years of age.
•b.Volunteers with MPOD level between 0.2 â?? 0.4
•c.Volunteers having no clinically significant ocular pathological condition, but clinically non-significant problem with accommodation of the eye can be included.
•d.Able to abide the dietary regime mentioned in the protocol
•e.Willing to come for regular follow â??up visits.
•f.Able to give written informed consent

•a.Known history of hypersensitivity to herbal extracts or dietary supplements.
•b.Volunteers having other ocular pathologies like glaucoma, mature cataract, pan retinal degenerations etc. will be excluded.
•c.Volunteers having systemic diseases like hyper-cholesterolemia, renal disorder, liver disorder, diabetes mellitus and other debilitating diseases.
•d.On-going treatment with herbals or allopathic ocular drugs.
•e.History of having received any investigational drug or participated in any other clinical trial which ended in the preceding three months or currently ongoing.
•f.Any condition that in the opinion of the investigator does not justify the patientâ??s inclusion for the study

发起方